Lithium technology has ushered in a new era of batteries with exceptionally high energy density for a reasonably low cost.

The decision to go all-in on the programme comes two years after BMS paid $80 million to take exclusive, worldwide opt-in rights to PRX005, and means that the big pharma will now be responsible ...